Dec 19 Abbvie Inc
* Abbvie is on track to submit a marketing authorization application for g/p in european union in early 2017
* Abbvie submits new drug application to u.s. Fda for its investigational regimen of glecaprevir/pibrentasvir (g/p) for the treatment of all major genotypes of chronic hepatitis c Source text for Eikon: Further company coverage:
Kraft withdraws offer to merge with Unilever
UPDATE 3-SpaceX launches rocket from historic NASA pad in Florida
CAPE CANAVERAL, Fla., Feb 19 A SpaceX Falcon rocket blasted off on Sunday from a Florida launch pad once used to send NASA astronauts to the moon, a step forward for billionaire entrepreneur Elon Musk and his company's goal of ferrying astronauts to the International Space Station. The 229-foot tall (70-meter) Falcon 9 soared off a seaside launchpad at the Kennedy Space Center at 9:39 a.m. ET (1439 GMT) carrying a Dragon cargo ship bound for the station.